Navigation Links
Patient Doing Well Weeks After Historic 4-level AxioMed Viscoelastic Disc Replacement
Date:2/16/2017

AxioMed announced today the success of the first viscoelastic 4-level cervical case. Dr. Kingsley Chin, professor and Harvard trained surgeon, completed the procedure on Monday, Jan. 30 at Andrews Memorial Hospital in Kingston, Jamaica. The procedure was performed on a 55-year-old practicing female physician suffering from degenerative disc disease with radiculomyelopathy, as a result of degenerative cervical discs at levels C3-7. The patient failed conservative treatments prior to undergoing surgery.

Dr. Chin believes that viscoelastic disc technology will broaden the indication of cervical and lumbar treatment to include patients with abnormal alignment and motion, and will also treat patients that would classically qualify for fusion. Dr. Chin also believes that the design can be customized to treat scoliosis without fusion.

The AxioMed viscoelastic disc is a next-generation disc replacement that restores natural disc alignment and motion. The AxioMed disc is the most advanced in comparison to other disc replacement devices because its simple design and polymer core restores all natural disc characteristics such as height, lordosis, stability, and motion in the human spine. To view a side by side of disc motion vs. natural spine motion, visit https://www.youtube.com/watch?v=tq-lK5-p3sQ.

Dr. Chin, a former Bohlman fellow, said, “I can only imagine the pride Dr. Bohlman would feel with this type of innovation; he was always a proponent of anterior solutions to cervical spine disease.” Dr. Chin continued, “The AxioMed cervical disc is extremely easy to implant and has a great anatomical fit for restoring natural motion in the cervical spine.”

Jake Lubinski, president of AxioMed, was present during the procedure and added, “The simplicity and reliability of the AxioMed disc technology makes it ideal for surgeons of any level of training or technical proficiency to use the disc. Dr. Chin used very little fluoroscopy to get ideal placement, because you can actually see around the inserter and implant as it’s being implanted.”

Dr. Chin was born in Jamaica and has been doing surgery there for the last ten years. He expressed good fortune to be able to offer this technology to Jamaicans. “There is no need for expensive equipment, so doing this procedure in developing countries isn’t difficult; you can expect superior results over fusion or first generation disc replacement.” Dr. Chin believes this makes the AxioMed disc the ideal candidate for expanding medical tourism in countries like Jamaica, which is geographically advantageous for patients looking for AxioMed access while waiting for USA FDA clearance.

About AxioMed
Founded in 2001, AxioMed began its journey of exhaustively proving the Freedom® Disc through clinical studies in the USA and Europe, research, development, and testing. In 2014, KICVentures recognized the disc’s enormous potential and acquired the company into their healthcare portfolio. AxioMed owns an exclusive viscoelastic material license on its proprietary Freedom Disc technology.

Read the full story at http://www.prweb.com/releases/2017/02/prweb14071809.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related biology technology :

1. BERG Initiates Phase I/II Monotherapy Trial of BPM 31510-IV in Patients with Glioblastoma Multiforme (GBM)
2. Envisia Therapeutics Releases Interim ENV515 (Travoprost XR) Phase 2 Data Demonstrating 11-Month Duration-of-Action After a Single Dose in Patients With Glaucoma
3. The Conference Forum Announces 4th Annual “Patients as Partners” US Event
4. MedAvante Names Leader for Patient-Focused eSolutions
5. Asterias Announces Additional Motor Function Improvement at 6-months and 9-months Following Treatment with AST-OPC1 in Patients with Complete Cervical Spinal Cord Injuries
6. Resverlogix Provides Groundbreaking Results in Patients with Severe Kidney Impairments
7. Boston Biomedical to Highlight Data for Cancer Stemness Inhibitor Napabucasin in Patients with Colorectal Cancer at 2017 ASCO GI
8. Harris Poll: Only Nine Percent of U.S. Consumers Believe Pharma and Biotechnology Put Patients over Profits; Only 16 Percent Believe Health Insurers Do
9. Malaria Drug Successfully Treats 26-year-old Brain Cancer Patient
10. Vtesse Announces Dosing of First Patient in Australia in Phase 2b/3 Clinical Trial of VTS-270 in Niemann-Pick Type C1 Disease
11. Invitae acquires patient-centered data company AltaVoice, creating new offerings to advance research and access to care for patients with inherited and rare diseases
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/28/2017)... ... February 28, 2017 , ... RoviSys, a ... today that it has joined the Cisco® Digital Solutions Integrator Program. As a ... hardware and software that addresses Industrial IT and Business IT in manufacturing environments. ...
(Date:2/28/2017)... ... , ... Over 8,000 recognized rare diseases afflict an estimated 350 million people ... March 7, DrugDev will gather international experts to share challenges and provide insight and ... Overcoming the Challenges of Rare Disease Clinical Trials, Date: March 7, 2017, Time: 10:00-11:00 ...
(Date:2/28/2017)... ... February 28, 2017 , ... GigaGen Inc ... millions-diverse immune repertoires, today announced a strategic partnership with Trianni, Inc. , ... express human antibodies. The partnership will use GigaGen technology to discover immuno-oncology antibody ...
(Date:2/28/2017)... and PHILADELPHIA , Feb. 28, 2017 ... held biopharmaceutical company focusing on debilitating diseases including rare ... announced that the company joins with the National Organization ... advocacy and support around the world in commemorating Rare ... unique challenges and needs of the millions of patients ...
Breaking Biology Technology:
(Date:2/27/2017)... Feb. 27, 2017   Strategic Cyber Ventures , ... has led a $3.5 million investment in  Polarity , ... Cyber Ventures is DC based and is led by ... Thomas . Ron Gula , also a longtime ... participated in this series A round of funding. This ...
(Date:2/24/2017)... Feb. 24, 2017  EyeLock LLC, a leader of iris-based ... iris biometric solution on the latest Qualcomm® Snapdragon™ ... Mobile World Congress 2017 (February 27 – ... Hall 3, Stand 3E10. The ... security platform—a combination of hardware, software and ...
(Date:2/21/2017)... ARMONK, N.Y. and PORTLAND, Ore. ... IBM ) and the Avamere Family of Companies (Avamere ... Care) today announced a six-month research study that will ... caregivers improve eldercare at senior living and health centers. ... facilities, Avamere hopes to gain insights into physical and ...
Breaking Biology News(10 mins):